Page 13 - Margin Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares in these companies were trading above $300 in 2021 and they have what it takes to return to those levels in time.

With the stock down by more than 75% over the past six months, this fintech looks like an excellent buy-and-hold investment.

You could turn that relatively small annual investment into more than $1 million dollars with enough time and the right growth stock.

Author Bio Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi What's more exciting (to cannabis investors, at least) than growing a massive amount of marijuana? If you said, "combining the holdings of two major cultivators to grow a truly colossal amount of marijuana,...

Author Bio Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter. Follow @adria_in_paris Every 30 seconds, a sur...